Viewing Study NCT03141203


Ignite Creation Date: 2025-12-24 @ 7:39 PM
Ignite Modification Date: 2026-03-29 @ 9:54 PM
Study NCT ID: NCT03141203
Status: COMPLETED
Last Update Posted: 2022-05-18
First Post: 2017-02-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluation of the Combination of Romidepsin and Carfilzomib in Relapsed/Refractory Peripheral T Cell Lymphoma Patients
Sponsor: University of Birmingham
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Annotation Module